Table 3.

Adverse Effects Categorized by Body System for Each Dose of Resveratrol During the Study

Body System	250 mg/d	500 mg/d	1,000 mg/d	Total
Cardiac	2 (4.8)	1 (4)	0 (0)	3 (3.3)
Ear	0 (0)	1 (4)	0 (0)	1 (1.1)
Endocrine	1 (2.4)	0 (0)	1 (4)	2 (2.2)
GI	17 (40.5)	12 (48)	14 (56)	43 (46.7)
General disorders	2 (4.8)	1 (4)	3 (12)	6 (6.5)
Hepatobiliary	1 (2.4)	0 (0)	0 (0)	1 (1.1)
Infections and infestations	7 (16.7)	1 (4)	3 (12)	11 (11.9)
Musculoskeletal and connective tissue	3 (7.1)	4 (16)	0 (0)	7 (7.6)
Nervous system	4 (9.5)	2 (8)	1 (4)	7 (7.6)
Psychiatric	1 (2.4)	0 (0)	0 (0)	1 (1.1)
Renal and urinary	1 (2.4)	0 (0)	0 (0)	1 (1.1)
Reproductive system	0 (0)	0 (0)	1 (4)	1 (1.1)
Respiratory	2 (4.8)	1 (4)	0 (0)	3 (3.3)
Skin and subcutaneous tissue	1 (2.4)	1 (4)	2 (8)	4 (4.3)
Vascular	0 (0)	1 (4)	0 (0)	1 (1.1)
Total	42 (100)	25 (100)	25 (100)	92 (100)

Data are presented as No. (%).